Javascript must be enabled to continue!
Guanosine and its modified derivatives are endogenous ligands for TLR7
View through CrossRef
Abstract
Toll-like receptor (TLR) 7and 8 were considered to recognize single-strand RNA (ssRNA) from viruses. Although these receptors also respond to synthetic small chemical ligands, such as CL075 and R848, it remains to be determined whether these receptors sense natural small molecules or not. In the structure of human TLR8 (huTLR8) with ssRNA, there are two ligand-binding sites: one binds a uridine and the other binds an oligoribonucleotide (ORN). This finding demonstrates that huTLR8 recognizes degradation products of ssRNA, suggesting the presence of natural small ligands. We here show that TLR7 works as the sensor for guanosine (G)/2′-deoxyguanosine (dG) in the presence of ORN where ORN strengthens TLR7 interaction with G/dG. In addition, modified nucleosides such as 7-methylguanosine, 8-hydroxyguanosine (8-OHG) and 8-hydroxydeoxyguanosine (8-OHdG) activated TLR7 with ORNs. Importantly, 8-OHdG—a well-known oxidative DNA damage marker with unknown function—induced strong cytokine production comparable to G and dG both in mouse and human immune cells. Although 8-OHdG bound TLR7/ORN with lower affinity than dG did in isothermal titration calorimetry, administered 8-OHdG was metabolically more stable than dG in the serum, indicating that 8-OHdG acts on TLR7 as an endogenous ligand in vivo. To address a role of G analogs in the disease state, we also examined macrophages from Unc93b1D34A/D34A mice, which suffer from TLR7-dependent systemic inflammation, and found that Unc93b1D34A/D34A macrophages showed significantly enhanced response to G alone or 8-OHdG with ORN. In conclusion, our results provide evidence that G, dG, 8-OHG and 8-OHdG are novel endogenous ligands for TLR7.
Title: Guanosine and its modified derivatives are endogenous ligands for TLR7
Description:
Abstract
Toll-like receptor (TLR) 7and 8 were considered to recognize single-strand RNA (ssRNA) from viruses.
Although these receptors also respond to synthetic small chemical ligands, such as CL075 and R848, it remains to be determined whether these receptors sense natural small molecules or not.
In the structure of human TLR8 (huTLR8) with ssRNA, there are two ligand-binding sites: one binds a uridine and the other binds an oligoribonucleotide (ORN).
This finding demonstrates that huTLR8 recognizes degradation products of ssRNA, suggesting the presence of natural small ligands.
We here show that TLR7 works as the sensor for guanosine (G)/2′-deoxyguanosine (dG) in the presence of ORN where ORN strengthens TLR7 interaction with G/dG.
In addition, modified nucleosides such as 7-methylguanosine, 8-hydroxyguanosine (8-OHG) and 8-hydroxydeoxyguanosine (8-OHdG) activated TLR7 with ORNs.
Importantly, 8-OHdG—a well-known oxidative DNA damage marker with unknown function—induced strong cytokine production comparable to G and dG both in mouse and human immune cells.
Although 8-OHdG bound TLR7/ORN with lower affinity than dG did in isothermal titration calorimetry, administered 8-OHdG was metabolically more stable than dG in the serum, indicating that 8-OHdG acts on TLR7 as an endogenous ligand in vivo.
To address a role of G analogs in the disease state, we also examined macrophages from Unc93b1D34A/D34A mice, which suffer from TLR7-dependent systemic inflammation, and found that Unc93b1D34A/D34A macrophages showed significantly enhanced response to G alone or 8-OHdG with ORN.
In conclusion, our results provide evidence that G, dG, 8-OHG and 8-OHdG are novel endogenous ligands for TLR7.
Related Results
Activation of Toll‐like receptor 7 provides cardioprotection in septic cardiomyopathy‐induced systolic dysfunction
Activation of Toll‐like receptor 7 provides cardioprotection in septic cardiomyopathy‐induced systolic dysfunction
ABSTRACTBackgroundAs a pattern recognition receptor, Toll‐like receptor 7 (TLR7) widely presented in the endosomal membrane of various cells. However, the precise role and mechanis...
Etude du biais de sexe dans la transcription des gènes de récepteurs Toll-like liés à l'X, TLR7 et TLR8
Etude du biais de sexe dans la transcription des gènes de récepteurs Toll-like liés à l'X, TLR7 et TLR8
Les récepteurs endosomaux humains TLR7 et TLR8 reconnaissent les ligands d'ARN simple brin du soi et du non-soi, et sont des médiateurs importants de l'immunité innée et de la path...
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines
Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines
AbstractAlthough glycoconjugate vaccines are generally very efficacious, there is still a need to improve their efficacy, especially in eliciting a strong primary antibody response...
TLR8, TLR9 and Gfi-1 restrain TLR7-mediated lupus
TLR8, TLR9 and Gfi-1 restrain TLR7-mediated lupus
Le lupus érythémateux disseminé (LED) est une maladie chronique auto-immune caractérisée par la production d'autoanticorps dirigés contre les antigènes nucléaires. Des nombreuses é...
Evidence for Genes in Addition to Tlr7 in the Yaa Translocation Linked with Acceleration of Systemic Lupus Erythematosus
Evidence for Genes in Addition to Tlr7 in the Yaa Translocation Linked with Acceleration of Systemic Lupus Erythematosus
Abstract
The accelerated development of systemic lupus erythematosus (SLE) in male BXSB mice is associated with the genetic abnormality in its Y chromosome, designat...
Increased expression of the TLR7/9 signaling pathways in chronic active EBV infection
Increased expression of the TLR7/9 signaling pathways in chronic active EBV infection
We aimed to investigate the immunological mechanisms of the Toll-like receptor (TLR) signaling pathways in different types of Epstein-Barr virus (EBV) infection. We retrospectively...
Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
Theranostic Small-Molecule Prodrug Conjugates for Targeted Delivery and Controlled Release of Toll-like Receptor 7 Agonists
We previously reported the design and synthesis of a small-molecule drug conjugate (SMDC) platform that demonstrated several advantages over antibody–drug conjugates (ADCs) in term...
Novel TLR7 hemizygous variant in post-COVID-19 neurological deterioration: a case report with literature review
Novel TLR7 hemizygous variant in post-COVID-19 neurological deterioration: a case report with literature review
The neurological complications of coronavirus disease 2019 (COVID-19) can range from simple tremors and dystonia to features of encephalopathy. Toll-like receptor 7 (TLR7) belongs ...

